Airmark Clinical Technology Valdosta, GA - 31602

Airmark Clinical Technology is categorized under Business Management Consultants in Valdosta, GA and active since 2003.

Airmark Clinical Technology was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Business Management Consultants business, which does work in the B2B market, and is classified as a Business Management Consultants, under code number 541611 by the NAICS.

If you are seeking more information, feel free to contact Bud Caster at the company’s single location by writing to 2501 North Patterson St, Valdosta, Georgia GA 31602 or by phoning (229) 259-4071. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Airmark Clinical Technology
Contact Person: Bud Caster
Address: 2501 North Patterson St, Valdosta, Georgia 31602
Phone Number: (229) 259-4071
Annual Revenue (USD): $100.000 to $499.999
Founded: 2003
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Management Consultants
SIC Code: 8742
NAICS Code: 541611
Share This Business:

Airmark Clinical Technology was started in 2003 to provide professional Business Management Consultants under the SIC code 8742 and NAICS code 541611. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Bud Caster for inquiries that concern Airmark Clinical Technology by calling the company number (229) 259-4071, as your correspondence is most welcome. Additionally, the physical location of the single location of Airmark Clinical Technology can be found at the coordinates 30.861757,-83.288721 as well as the street address 2501 North Patterson St in Valdosta, Georgia 31602.

For its online presence, you may visit Airmark Clinical Technology’s website at and engage with its social media outlets through on Twitter and on Facebook.